Build a Pet Dinosaur or Your Perfect Child
By Christine Rosen,
Slate
| 12. 10. 2014
Untitled Document
If Silicon Valley has anything like a coherent philosophy, it is summed up in the idea that the best way to predict the future is to invent it. Innovation is to the technology industry in the 21st century what the Feejee Mermaid was to P.T. Barnum in the 19th—a manufactured ideal, relentlessly and hyperbolically promoted and frequently documented in credulous accounts by the technology press and popular science writers, many of whom have adopted the perpetually fawning posture of subjects backing away from a monarch.
But Silicon Valley’s second-order philosophy might be “Don’t Tread on Me.” While a libertarian approach might be harmless when it comes to the question of regulating the latest dating app, the stakes are much higher in fields such as synthetic biology, where the ambitions of private companies go far beyond increasing advertising revenue to embrace the design and construction of new forms of life.
Synthetic biology entrepreneurs want each of us to become gods of our own creations. “Anyone with a smartphone and a credit card will be able to get to creature,”...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...